Andrews Karen L, Irvine Jennifer C, Tare Marianne, Apostolopoulos Jacqueline, Favaloro Joanne L, Triggle Chris R, Kemp-Harper Barbara K
Discipline of Pharmaceutical Sciences, RMIT University, Bundoora, Victoria, Australia.
Br J Pharmacol. 2009 Jun;157(4):540-50. doi: 10.1111/j.1476-5381.2009.00150.x. Epub 2009 Mar 26.
Nitroxyl (HNO) is emerging as an important regulator of vascular tone as it is potentially produced endogenously and dilates conduit and resistance arteries. This study investigates the contribution of endogenous HNO to endothelium-dependent relaxation and hyperpolarization in resistance arteries.
Rat and mouse mesenteric arteries were mounted in small vessel myographs for isometric force and smooth muscle membrane potential recording.
Vasorelaxation to the HNO donor, Angeli's salt, was attenuated in both species by the soluble guanylate cyclase inhibitor (ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one), the voltage-dependent K(+) channel inhibitor, 4-aminopyridine (4-AP) and the HNO scavenger, L-cysteine. In mouse mesenteric arteries, nitric oxide (NO) synthase inhibition (with L-NAME, N(omega)-Nitro-L-arginine methyl ester) markedly attenuated acetylcholine (ACh)-mediated relaxation. Scavenging the uncharged form of NO (NO()) with hydroxocobalamin (HXC) or HNO with L-cysteine, or 4-AP decreased the sensitivity to ACh, and a combination of HXC and L-cysteine reduced ACh-mediated relaxation, as did L-NAME alone. ACh-induced hyperpolarizations were significantly attenuated by 4-AP alone and in combination with L-NAME. In rat mesenteric arteries, blocking the effects of endothelium-derived hyperpolarizing factor (EDHF) (charybdotoxin and apamin) decreased ACh-mediated relaxation 10-fold and unmasked a NO-dependent component, mediated equally by HNO and NO(), as HXC and L-cysteine in combination now abolished vasorelaxation to ACh. Furthermore, ACh-evoked hyperpolarizations, resistant to EDHF inhibition, were virtually abolished by 4-AP.
The factors contributing to vasorelaxation in mouse and rat mesenteric arteries are NO() = HNO > EDHF and EDHF > HNO = NO() respectively. This study identified HNO as an endothelium-derived relaxing and hyperpolarizing factor in resistance vessels.
硝酰(HNO)正逐渐成为血管张力的重要调节因子,因为它可能在内源性产生,并使传导动脉和阻力动脉扩张。本研究调查内源性HNO对阻力动脉内皮依赖性舒张和超极化的作用。
将大鼠和小鼠的肠系膜动脉安装在小血管肌张力描记仪上,用于记录等长力和平滑肌膜电位。
可溶性鸟苷酸环化酶抑制剂(ODQ,1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮)、电压依赖性钾通道抑制剂4-氨基吡啶(4-AP)和HNO清除剂L-半胱氨酸,均减弱了两种动物对HNO供体安吉利盐的血管舒张作用。在小鼠肠系膜动脉中,一氧化氮(NO)合酶抑制(使用L-NAME,N(ω)-硝基-L-精氨酸甲酯)显著减弱乙酰胆碱(ACh)介导的舒张。用羟钴胺素(HXC)清除不带电荷形式的NO(NO*)或用L-半胱氨酸清除HNO,或使用4-AP,均可降低对ACh的敏感性,HXC和L-半胱氨酸联合使用可降低ACh介导的舒张,单独使用L-NAME也有同样效果。单独使用4-AP以及与L-NAME联合使用时,均可显著减弱ACh诱导的超极化。在大鼠肠系膜动脉中,阻断内皮源性超极化因子(EDHF)的作用(使用蝎毒素和蜂毒明肽)使ACh介导的舒张降低了10倍,并揭示出一个NO依赖性成分,由HNO和NO*同等介导,因为HXC和L-半胱氨酸联合使用现在消除了对ACh的血管舒张作用。此外,对EDHF抑制有抗性的ACh诱发的超极化,实际上被4-AP消除。
在小鼠和大鼠肠系膜动脉中,促成血管舒张的因素分别为NO* = HNO > EDHF和EDHF > HNO = NO*。本研究确定HNO是阻力血管中一种内皮源性舒张和超极化因子。